CAPTRUST Financial Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.3M | Buy |
151,265
+11,674
| +8% | +$1.41M | 0.04% | 327 |
|
|
2025
Q1 | $15.6M | Buy |
139,591
+17,927
| +15% | +$2M | 0.04% | 334 |
|
|
2024
Q4 | $11.8M | Sell |
121,664
-9,381
| -7% | -$913K | 0.03% | 334 |
|
|
2024
Q3 | $15.1M | Buy |
131,045
+1,730
| +1% | +$199K | 0.04% | 290 |
|
|
2024
Q2 | $13.8M | Buy |
129,315
+2,534
| +2% | +$270K | 0.04% | 291 |
|
|
2024
Q1 | $12.3M | Sell |
126,781
-14,338
| -10% | -$1.39M | 0.05% | 309 |
|
|
2023
Q4 | $14.2M | Buy |
141,119
+747
| +0.5% | +$75.4K | 0.05% | 298 |
|
|
2023
Q3 | $14.3M | Buy |
140,372
+10,829
| +8% | +$1.1M | 0.05% | 260 |
|
|
2023
Q2 | $13.1M | Buy |
129,543
+15,196
| +13% | +$1.53M | 0.05% | 269 |
|
|
2023
Q1 | $10.5M | Buy |
114,347
+4,285
| +4% | +$394K | 0.05% | 285 |
|
|
2022
Q4 | $9.98M | Sell |
110,062
-744
| -0.7% | -$67.5K | 0.05% | 296 |
|
|
2022
Q3 | $8.42M | Buy |
110,806
+14,877
| +16% | +$1.13M | 0.05% | 295 |
|
|
2022
Q2 | $8.11M | Buy |
95,929
+9,410
| +11% | +$795K | 0.05% | 280 |
|
|
2022
Q1 | $7.59M | Buy |
86,519
+1,645
| +2% | +$144K | 0.05% | 276 |
|
|
2021
Q4 | $7.42M | Buy |
84,874
+1,975
| +2% | +$173K | 0.05% | 284 |
|
|
2021
Q3 | $6.78M | Buy |
82,899
+4,505
| +6% | +$368K | 0.06% | 268 |
|
|
2021
Q2 | $7.15M | Sell |
78,394
-2,691
| -3% | -$246K | 0.07% | 244 |
|
|
2021
Q1 | $6.93M | Buy |
81,085
+3,362
| +4% | +$287K | 0.08% | 232 |
|
|
2020
Q4 | $7.34M | Buy |
77,723
+2,259
| +3% | +$213K | 0.1% | 195 |
|
|
2020
Q3 | $6.59M | Sell |
75,464
-948
| -1% | -$82.8K | 0.11% | 184 |
|
|
2020
Q2 | $6.71M | Buy |
76,412
+3,455
| +5% | +$304K | 0.11% | 184 |
|
|
2020
Q1 | $5.9M | Buy |
72,957
+410
| +0.6% | +$33.2K | 0.13% | 175 |
|
|
2019
Q4 | $6.89M | Buy |
+72,547
| New | +$6.89M | 0.11% | 190 |
|